Reported Consolidated quarterly numbers for GlaxoSmithKline Pharmaceuticals are:Net Sales at Rs 761.66 crore in June 2023 up 2.22% from Rs. 745.10 crore in June 2022.
Quarterly Net Profit at Rs. 132.25 crore in June 2023 up 10.87% from Rs. 119.28 crore in June 2022.
EBITDA stands at Rs. 180.32 crore in June 2023 up 2.15% from Rs. 176.53 crore in June 2022.
GlaxoSmithKline EPS has decreased to Rs. 7.04 in June 2023 from Rs. 7.04 in June 2022.
| GlaxoSmithKline shares closed at 1,401.40 on July 26, 2023 (NSE) and has given 10.96% returns over the last 6 months and -4.11% over the last 12 months. |
| GlaxoSmithKline Pharmaceuticals | | Consolidated Quarterly Results | in Rs. Cr. |
|
| Jun'23 | Mar'23 | Jun'22 | | Net Sales/Income from operations | 761.66 | 787.45 | 745.10 | | Other Operating Income | -- | -- | -- | | Total Income From Operations | 761.66 | 787.45 | 745.10 | | EXPENDITURE | | Consumption of Raw Materials | 158.41 | 94.10 | 153.78 | | Purchase of Traded Goods | 174.20 | 177.79 | 271.60 | | Increase/Decrease in Stocks | -36.49 | 72.90 | -138.48 | | Power & Fuel | -- | -- | -- | | Employees Cost | 165.00 | 148.84 | 151.22 | | Depreciation | 16.36 | 17.18 | 15.82 | | Excise Duty | -- | -- | -- | | Admin. And Selling Expenses | -- | -- | -- | | R & D Expenses | -- | -- | -- | | Provisions And Contingencies | -- | -- | -- | | Exp. Capitalised | -- | -- | -- | | Other Expenses | 156.66 | 124.08 | 158.06 | | P/L Before Other Inc., Int., Excpt. Items & Tax | 127.52 | 152.56 | 133.10 | | Other Income | 36.44 | 27.66 | 27.61 | | P/L Before Int., Excpt. Items & Tax | 163.96 | 180.22 | 160.71 | | Interest | 0.28 | 0.65 | 0.68 | | P/L Before Exceptional Items & Tax | 163.68 | 179.57 | 160.03 | | Exceptional Items | 17.30 | 10.40 | -- | | P/L Before Tax | 180.98 | 189.97 | 160.03 | | Tax | 48.73 | 56.54 | 43.80 | | P/L After Tax from Ordinary Activities | 132.25 | 133.43 | 116.23 | | Prior Year Adjustments | -- | -- | -- | | Extra Ordinary Items | -- | -- | 3.05 | | Net Profit/(Loss) For the Period | 132.25 | 133.43 | 119.28 | | Minority Interest | -- | -- | -- | | Share Of P/L Of Associates | -- | -- | -- | | Net P/L After M.I & Associates | 132.25 | 133.43 | 119.28 | | Equity Share Capital | 169.41 | 169.41 | 169.41 | | Reserves Excluding Revaluation Reserves | -- | -- | -- | | Equity Dividend Rate (%) | -- | -- | -- | | EPS Before Extra Ordinary | | Basic EPS | 7.04 | 7.41 | 7.04 | | Diluted EPS | 7.81 | 7.41 | 7.04 | | EPS After Extra Ordinary | | Basic EPS | 7.04 | 7.88 | 7.04 | | Diluted EPS | 7.81 | 7.88 | 7.04 | | Public Share Holding | | No Of Shares (Crores) | -- | -- | -- | | Share Holding (%) | -- | -- | -- | | Promoters and Promoter Group Shareholding | | a) Pledged/Encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | b) Non-encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | Source : Dion Global Solutions Limited |
|
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
